OIG: Medicare Spent $366 Million More by Including Self-Administered Drugs in Part B Calculations

Drug Industry Daily
Medicare and its beneficiaries would face significantly lower costs for drugs if the Centers for Medicare and Medicaid Services excluded noncovered versions of drugs while setting Part B drug payments, according to the HHS Office of Inspector General.

To View This Article:


Subscribe To Drug Industry Daily